Statin Myopathy SLCO1B1 Risk Score

Estimate statin-induced myopathy risk from SLCO1B1 *5 variant. C allele carriers have 4.5x higher myopathy risk on high-dose simvastatin.

Weight
Height
Clinical Guidance

BMI is a screening measure of body size, not a direct measure of body fat. The standard WHO categories are underweight (<18.5), normal (18.5–24.9), overweight (25–29.9), and obese (≥30).

BMI can overestimate body fat in athletes with high muscle mass and underestimate it in older adults with low muscle mass. Interpret it alongside waist circumference and clinical context rather than as a standalone diagnosis.

⚕ Clinical Disclaimer: These calculators are for educational and reference purposes only. Always verify results with qualified clinical judgment and current clinical guidelines. Do not use as a sole basis for medical decisions.
Advertisement

How It Works

Estimate statin-induced myopathy risk from SLCO1B1 *5 variant. C allele carriers have 4.5x higher myopathy risk on high-dose simvastatin

Each component has a specific meaning:

  • SLCO1B1 *5 variant — The slco1b1 *5 variant recorded for the scenario being assessed.

Note: Interpret the statin slco1b1 result against the thresholds and context described above.

How to Use

Enter the SLCO1B1 *5 variant for the scenario you are assessing. Estimate statin-induced myopathy risk from SLCO1B1 *5 variant. C allele carriers have 4.5x higher myopathy risk on high-dose simvastatin. Use the statin slco1b1 result to inform your calculation.

Related Calculators

Simvastatin CYP3A4

Medical Ultra-depth

Atorvastatin SLCO1B1

Medical Ultra-depth

Frequently Asked Questions